Involvement of p53 and interleukin 3 in the up-regulation of CD95 (APO-1/Fas) by X-ray irradiation

Oncogene

Volumn 19, Issue 32, 2000, Pages 3647-3655

  Gutierrez Del Arroyo A ^a   Gil Lamagniere, C ^a   Lazaro, I ^a   De Marco, M C ^a   Layunta, I ^a   Silva, A ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

Apoptosis; CD95 (Fas Apo 1); IL 3; p53; X ray irradiation

Indexed keywords

FAS ANTIGEN; INTERLEUKIN 3; PROTEIN P53;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL LINE; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; X IRRADIATION;

ANIMALIA;

EID: 0034721094     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203662     Document Type: Article

References (49)

1. Akagi T, Yoshino T and Kondo E. (1998). Leuk. Lymphoma, 28, 483-489.
2. Ashkenazi A and Dixit VM. (1998). Science, 281, 1305-1308.
3. Boldin MP, Goncharov TM Goltsev YV and Wallach D. (1996). Cell, 85, 803-815.
4. Booker JK, Reap EA and Cohen PL. (1998). J. Immunol., 161, 4536-4541.
5. Canman CE, Gilmer TM, Coutts SB and Kastan MB. (1995). Genes Dev., 9, 600-611.
6. Chinnaiyan AM and Dixit VM. (1997). Semin. Immunol., 9, 69-76.
7. Chinnaiyan AM, O'Rourke K, Tewari N and Dixit VM. (1995). Cell, 81, 505-512.
8. Collins MKL, Marvel J, Malde P and Lopez-Rivas A. (1992). J. Exp. Med., 176, 1043-1051.
9. Eberstadt M, Huang B, Olejniczak ET and Fesik SW. (1997). Nat. Struct. Biol., 4, 983-985.
10. French LE, Hahne M, Viard I, Radlgruber G, Zanone R, Becker K, Muller C and Tschopp J. (1996). J. Cell Biol., 133, 335-343.
11. Friesen C, Herr I, Krammer PH and Debatin KM. (1996). Nat. Med., 2, 574-580.
12. Fukazawa T, Fujiwara T, Morimoto Y, Shao J, Nishizaki M, Kadowaki Y, Hizuta A, Owen-Schaub LB, Roth JA and Tanaka N. (1999). Oncogene, 18, 2189-2199.
13. Fulda S, Sieverts H, Friesen C, Herr I and Debatin KM. (1997). Cancer Res., 57, 3823-3829.
14. Fulda S, Susin SA, Kroemer G and Debatin KM. (1998). Cancer Res., 58, 4453-4460.
15. Herr I, Wilhelm D, Böhler T, Angel P and Debatin KM. (1997). EMBO J., 16, 6200-6208.
16. Huang B, Eberstadt M, Olejniczak ET, Meadows RP and Resik SW. (1996). Nature, 384, 638-641.
17. Iwai K, Miyawaki T, Takizaha T, Konno A, Ohta K, Yachie A, Seki H and Taniguchi N. (1994). Blood, 84, 1201-1208.
18. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT and Weinberg RA. (1994). Current Biol., 4, 1-7.
19. Ko LJ and Prives C. (1996). Genes Dev., 10, 1054-1072.
20. Krammer PH, Dhein J and Walczak H. (1994). Immunology Review, 142, 175-191.
21. Leithouser F, Dhein J, Mechtersheimer G, Korcz K, Bruderlien S, Henne C, Schmidt A, Debatin M, Krammer P and Moller P. (1993). Lab. Invest., 69, 415-429.
22. Li T, Ramirez K and Palacios R. (1996). Cell Growth Differ., 7, 107-114.
23. Marvel J, Perkins GR, Lopez Rivas A and Collins MK. (1994). Oncogene, 9, 1117-1122.
24. Matsue H, Kobayashi H, Hosokawa T, Akitaya T and Ohkanawara A. (1995). Arch. Dermatol. Res., 287, 315-320.
25. Miyashita T and Reed JC. (1995). Cell. 80, 293-299.
26. Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S and Taniguchi N. (1992). J. Immunol., 149, 3753-3578.
27. Müller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, Stremmel W, Krammer PH and Galle PR. (1997). J. Clin. Invest., 99, 403-413.
28. Müller M, Wilder S, Bannasch D, Israeli D, Lehlbach K, LiWeber M, Friedman SL, Galle PR, Stremmel W, Oren M and Krammer PH. (1998). J. Exp. Med., 188, 2033-2045.
29. Müllner EW and Garcia-Sanz JA. (1997). Immunology Methods Manual CD-ROM. Lefkovits, I. (ed.). AP: San Diego.
30. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME and Dixit VM. (1996). Cell, 85, 817-827.
31. Nagata S. (1998). Cell, 88, 355-365.
32. Nagata S and Golstein P. (1995). Science, 267, 1449-1456.
33. Nagata S and Suda T. (1995). Immuniol. Today, 16, 39-43.
34. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T and Nagata S. (1993). Nature, 364, 806-809.
35. Owen-Schaub LB, Zhang W, Cusack JC, Angelo LS, Suntee SM, Fujiwara T, Roth JA, Deisseroth AB, Zhang WW, Kruzel E and Radinski R. (1995). Mol. Cell. Biol., 15, 3032-3040.
36. Palacios R and Steinmetz M. (1985). Cell, 41, 727-734.
37. Rehemtulla A, Hamilton C, Chinnaiyan A and Dixit V. (1997). J. Biol. Chem., 272, 25783-25786.
38. Rodriguez-Tarduchy G, Collins MKL and Lopez-Rivas A. (1990). EMBO J., 9, 2997-3002.
39. Rouvier E, Luciani M and Golstein P. (1993). J. Exp. Med., 177, 195-200.
40. Ruiz-Ruiz MC and Lopez-Rivas A. (1999). Cell Death Differ., 6, 271-280.
41. Sata M and Walsh K. (1988). Nature Med., 4, 415-420.
42. Schulze-Osthoff K. (1994). Trends Cell Biol., 4, 421-426.
43. Sheard MA, Vojtesek B, Janakova L, Kovarik J and Zaloudik J. (1997). Int. J. Cancer, 73, 757-762.
44. Silva A, Wyllie A and Collins M. (1997). Blood, 89, 2717-2722.
45. Strand S, Hofmann WJ. Grambihler A, Hug H, Volkmann M, Otto G, Wesch H, Mariani SM, Hack V, Stremmel W, Krummer PH and Galle PR. (1998). Nat. Med., 4, 588-593.
46. Strand S, Hofmann WJ, Hug H, Müller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH and Galle PR. (1996). Nat. Med., 2, 1361-1366.
47. Tamura T, Aoyama N, Saya H, Haga H, Futami S, Miyamoto M, Koh T, Ariyasu T, Tachi M and Kasuga M. (1995). Oncogene, 11, 1939-1946.
48. Warasukama H and Melchers F. (1988). Eur. J. Immunol., 18, 97-104.
49. White E. (1996). Genes Dev., 10, 1-15.